title: Ki-1 anaplastic large cell lymphoma.
authors.affiliation: Department of Dermatology and Genitourinary Medicine, Al Nahdha Hospital, Muscat, Sultanate of Oman.
authors.forename: V
authors.initials: V
authors.lastname: Mysore
authors.forename: S R
authors.initials: SR
authors.lastname: Bhusnurmath
authors.forename: D D
authors.initials: DD
authors.lastname: Banodkar
authors.forename: A R
authors.initials: AR
authors.lastname: al Suwaid
mesh_terms: D000284:Administration, Oral; D000708:Anaplasia; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000627:therapeutic use; D001365:Axilla; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy / Q000473:pathology*; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D010392:Pemphigus / Q000473:pathology; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000893:Anti-Inflammatory Agents; D018931:Antineoplastic Agents, Hormonal; D011239:Prednisolone; D008775:Methylprednisolone